Compare CCCC & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCCC | LAW |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.3M | 466.2M |
| IPO Year | 2020 | 2021 |
| Metric | CCCC | LAW |
|---|---|---|
| Price | $2.24 | $7.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.25 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.7M | 206.6K |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,108,000.00 | ★ $152,677,000.00 |
| Revenue This Year | N/A | $8.51 |
| Revenue Next Year | N/A | $8.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.33 |
| 52 Week Low | $1.09 | $3.31 |
| 52 Week High | $4.26 | $9.11 |
| Indicator | CCCC | LAW |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 44.52 |
| Support Level | $1.87 | $7.22 |
| Resistance Level | $2.19 | $8.33 |
| Average True Range (ATR) | 0.13 | 0.28 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 77.17 | 18.27 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.